BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 23, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
GR-175737: H3 antagonist for cognition disorders
May 10, 1996
Bayer reports K+ channel modulators for CNS disorders
May 10, 1996
New pediatric approval for Zofran in U.K.
May 10, 1996
Taro's antiepileptic drug in development in USA
May 10, 1996
Tocris Cookson will distribute SYM-2206 for research purposes
May 10, 1996
5-HT reuptake inhibitors reported by HMR
May 10, 1996
Taisho discloses new series of sigma-receptor ligands
May 10, 1996
Santen reports sigma receptor ligands as potential psychopharmacologic drugs
May 10, 1996
Naropin introduced in first markets
May 10, 1996
MK-462 deserves further study in migraine indication
May 10, 1996
Previous
1
2
…
2801
2802
2803
2804
2805
2806
2807
2808
2809
…
2814
2815
Next